Rapid advances in experimental technologies are creating new opportunities to understand cancer biology and develop innovative therapeutic strategies. This session provides a platform for forward-looking research involving novel models, advanced molecular technologies, gene editing, spatial and single-cell approaches, and emerging therapeutic platforms.
Abstract Scope and Participation
Submissions may include organoids, advanced tumor models, CRISPR and gene editing, single-cell technologies, spatial biology, nanotechnology, radiotheranostics, targeted radiopharmaceuticals, novel research platforms, and emerging cancer therapies. Researchers from academic, clinical, engineering, and industry backgrounds are invited.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States